-+ 0.00%
-+ 0.00%
-+ 0.00%

Prolight Diagnostics Signs Development Deal with BrainBox Solutions

MT Newswires·07/13/2026 01:53:48
Listen to the news
01:53 AM EDT, 07/13/2026 (MT Newswires) -- Prolight Diagnostics (PRLD.ST) said Monday it entered into a development agreement with medical technology platform BrainBox Solutions. The deal followed a 260-patient feasibility study and covers the development of multiplex cartridges, software, and the initial purchase of pilot instruments for the BrainBox system, which utilizes Prolight's Psyros platform with three assays for traumatic brain injury. The system is under US Food and Drug Administration review and Prolight said regulatory approval of the BrainBox system would also mark US market clearance for its Psyros platform. The innovative point-of-care systems developer expects to generate 2.2 million pounds sterling in total revenue from the deal.